BMI‑1 is important in bufalin‑induced apoptosis of K562 cells
- Authors:
- Xiaoyun Lian
- Hao Wang
- Xucang Wei
- Yi Wang
- Qishan Wang
- Liang Guo
- Yuan Zhao
- Xiequn Chen
-
Affiliations: Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Department of Hematology, Xi'an Central Hospital, Xi'an, Shaanxi 710003, P.R. China, Department of Hematology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, P.R. China - Published online on: February 21, 2014 https://doi.org/10.3892/mmr.2014.1980
- Pages: 1209-1217
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Krenn L and Kopp B: Bufadienolides from animal and plant sources. Phytochemistry. 48:1–29. 1998.PubMed/NCBI | |
|
Qi F, Li A, Inagaki Y, Kokudo N, Tamura S, Nakata M and Tang W: Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. Int Immunopharmacol. 11:342–349. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Takai N, Kira N, Ishii T, Yoshida T, Nishida M, Nishida Y, Nasu K and Narahara H: Bufalin, a traditional oriental medicine, induces apoptosis in human cancer cells. Asian Pac J Cancer Prev. 13:399–402. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Nakaya K, Yoshida T and Kuroiwa Y: Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res. 52:4634–4641. 1992. | |
|
Chen A, Yu J, Zhang L, Sun Y, Zhang Y, Guo H, Zhou Y, Mitchelson K and Cheng J: Microarray and biochemical analysis of bufalin-induced apoptosis of HL-60 cells. Biotechnol Lett. 31:487–494. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Huang C, Chen A, Guo M and Yu J: Membrane dielectric responses of bufalin-induced apoptosis in HL-60 cells detected by an electrorotation chip. Biotechnol Lett. 29:1307–1313. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Numazawa S, Shinoki MA, Ito H, Yoshida T and Kuroiwa Y: Involvement of Na+, K(+)-ATPase inhibition in K562 cell differentiation induced by bufalin. J Cell Physiol. 160:113–210. 1994. | |
|
Kawazoe N, Aiuchi T, Masuda Y, Nakajo S and Nakaya K: Induction of apoptosis by bufalin in human tumor cells is associated with a change of intracellular concentration of Na+ ions. J Biochem. 126:278–286. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Watabe M, Masuda Y, Nakajo S, Yoshida T, Kuroiwa Y and Nakaya K: The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells. J Biol Chem. 271:14067–14072. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Masuda Y, Kawazoe N, Nakajo S, Yoshida T, Kuroiwa Y and Nakaya K: Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk Res. 19:549–556. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Hashimoto S, Jing Y, Kawazoe N, Masuda Y, Nakajo S, Yoshidaz T, et al: Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leuk Res. 21:875–883. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Park IK, Qian D, Kiel M, et al: Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 423:302–305. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Dick JE: Stem cells: self-renewal writ in blood. Nature. 423:231–233. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Lessard J and Sauvageau G: Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 423:255–260. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Iwama A, Oguro H, Negishi M, et al: Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity. 21:843–851. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Alkema MJ, Wiegant J, Raap AK, Berns A and van Lohuizen M: Characterization and chromosomal localization of the human proto-oncogene BMI-1. Hum Mol Genet. 2:1597–1603. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Jacobs JJ, Kieboom K, Marino S, DePinho RA and van Lohuizen M: The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the Ink4a locus. Nature. 397:164–168. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Dhawan S, Tschen SI and Bhushan A: Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. Genes Dev. 23:906–911. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Schuringa JJ and Vellenga E: Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells. Curr Opin Hematol. 17:294–299. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lessard J and Sauvageau G: Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 423:255–260. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Valk-Lingbeek ME, Bruggeman SW and van Lohuizen M: Stem cells and cancer; the polycomb connection. Cell. 118:409–418. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu W, Huang L, Xu X, Qian H and Xu W: Anti-proliferation effect of BMI-1 in U937 cells with siRNA. Int J Mol Med. 25:889–895. 2010.PubMed/NCBI | |
|
Meng XX, Liu WH, Liu DD, Zhao XY and Su BL: Construction of antisense Bmi-1 expression plasmid and its inhibitory effect on K562 cells proliferation. Chin Med J (Engl). 118:1346–1350. 2005.PubMed/NCBI | |
|
Mehta RG, Murillo G, Naithani R and Peng X: Cancer chemoprevention by natural products: how far have we come? Pharm Res. 27:950–961. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge Y, Newman RA, Cohen L, Liu L, Thornton B, Chang DZ, Liao Z and Kurzrock R: Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer. 115:5309–5318. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kawazoe N, Aiuchi T, Masuda Y, Nakajo S and Nakaya K: Induction of apoptosis by bufalin in human tumor cells is associated with a change of intracellular concentration of Na+ ions. J Biochem. 126:278–286. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Yu CH, Kan SF, Pu HF, Jea Chien E and Wang PS: Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells. Cancer Sci. 99:2467–2476. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Z, Sun H, Ma G, Wang Z, Li E and Liu Y and Liu Y: Bufalin induces lung cancer cell apoptosis via the inhibition of PI3K/Akt pathway. Int J Mol Sci. 13:2025–2035. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sun L, Chen T, Wang X, Chen Y and Wei X: Bufalin induces reactive oxygen species dependent bax translocation and apoptosis in ASTC-a-1 cells. Evid Based Complement Alternat Med. 2011:2490902011.PubMed/NCBI | |
|
Wang YL, Qian J, Lin J, Yao DM, Qian Z, Zhu ZH and Li JY: Methylation status of DDIT3 gene in chronic myeloid leukemia. J Exp Clin Cancer Res. 29:542010. View Article : Google Scholar : PubMed/NCBI | |
|
Qian J, Chen Z, Lin J, Wang W and Cen J: Decreased expression of CCAAT/enhancer binding protein zeta (C/EBPzeta) in patients with different myeloid diseases. Leuk Res. 29:1435–1441. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Friedman AD: GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells. Cancer Res. 56:3250–3256. 1996.PubMed/NCBI | |
|
Matsumoto M, Minami M, Takeda K, Sakao Y and Akira S: Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells. FEBS Lett. 395:143–147. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Lu M, Chen F, Wang Q, Wang K, Pan Q and Zhang X: Downregulation of inhibitor of growth 3 is correlated with tumorigenesis and progression of hepatocellular carcinoma. Oncol Lett. 4:47–52. 2012.PubMed/NCBI | |
|
Ghosh AK, Steele R and Ray RB: Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation. Mol Cell Biol. 19:2880–2886. 1999.PubMed/NCBI | |
|
Ray R and Miller DM: Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol. 11:2154–2161. 1996.PubMed/NCBI | |
|
Chaudhary D and Miller DM: The c-myc promoter binding protein (MBP-1) and TBP bind simultaneously in the minor groove of the c-myc P2 promoter. Biochemistry. 34:3438–3445. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Ray RB: Induction of cell death in murine fibroblasts by a c-myc promoter binding protein. Cell Growth Differ. 6:1089–1096. 1995.PubMed/NCBI | |
|
Ghosh AK, Steele R, Ryerse J and Ray RB: Tumor-suppressive effects of MBP-1 in non-small cell lung cancer cells. Cancer Res. 66:11907–11912. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kim MK, Jeon BN, Koh DI, Park SY, Yun CO and Hur MW: Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKNIA) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding. J Biol Chem. 288:7053–7064. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Laity JH, Lee BM and Wright PE: Zinc finger proteins: new insights into structural and functional diversity. Curr Opin Struct Biol. 11:39–46. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Medvid R, Melton C, Jaenisch R and Blelloch R: DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet. 39:380–385. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Morello LG, Coltri PP, Quaresma AJ, Simabuco FM, Silva TC, Singh G, Nickerson JA, Oliveira CC, Moore MJ and Zanchin NI: The human nucleolar protein FTSJ3 associates with NIP7 and functions in pre-rRNA processing. PLoS One. 6:e291742011. View Article : Google Scholar : PubMed/NCBI | |
|
Tsuneoka M, Koda Y, Soejima M, Teye K and Kimura H: A novel myc target gene, mina53, that is involved in cell proliferation. J Biol Chem. 277:35450–35459. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Eilbracht J, Kneissel S, Hofmann A and Schmidt-Zachmann MS: Protein NO52-a constitutive nucleolar component sharing high sequence homologies to protein NO66. Eur J Cell Biol. 84:279–294. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Tan XP, Zhang Q, Dong WG, Lei XW and Yang ZR: Upregulated expression of Mina53 in cholangiocarcinoma and its clinical significance. Oncol Lett. 3:1037–1041. 2012.PubMed/NCBI | |
|
Bedford MT and Clarke SG: Protein arginine methylation in mammals: who, what, and why. Mol Cell. 33:1–13. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Gu Z, Li Y, Lee P, Liu T, Wan C and Wang Z: Protein arginine methyltransferase 5 functions in opposite ways in the cytoplasm and nucleus of prostate cancer cells. PLoS One. 7:e440332012. View Article : Google Scholar : PubMed/NCBI | |
|
Bao X, Zhao S, Liu T, Liu Y, Liu Y and Yang X: Overexpression of PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer. J Histochem Cytochem. 61:206–217. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gallant P: Control of transcription by Pontin and Reptin. Trends Cell Biol. 17:187–192. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Huber O, Ménard L, Haurie V, Nicou A, Taras D and Rosenbaum J: Pontin and reptin, two related ATPases with multiple roles in cancer. Cancer Res. 68:6873–6876. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Jha S and Dutta A: RVB1/RVB2: running rings around molecular biology. Mol Cell. 34:521–533. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Taniue K, Oda T, Hayashi T, Okuno M and Akiyama T: A member of the ETS family, EHF, and the ATPase RUVBL1 inhibit p53-mediated apoptosis. EMBO Rep. 12:682–689. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ito S, Ishii A, Kakusho N, Taniyama C, Yamazaki S, Fukatsu R, Sakaue-Sawano A, Miyawaki A and Masai H: Mechanism of cancer cell death induced by depletion of an essential replication regulator. PLoS One. 7:e363722012. View Article : Google Scholar : PubMed/NCBI | |
|
Montagnoli A, Tenca P, Sola F, Carpani D, Brotherton D, Albanese C and Santocanale C: Cdc7 inhibition reveals a p53-dependent replication checkpoint that is defective in cancer cells. Cancer Res. 64:7110–7116. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Tudzarova S, Trotter MW, Wollenschlaeger A, Mulvey C, Godovac-Zimmermann J, Williams GH and Stoeber K: Molecular architecture of the DNA replication origin activation checkpoint. EMBO J. 29:3381–3394. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Im JS and Lee JK: ATR-dependent activation of p38 MAP kinase is responsible for apoptotic cell death in cells depleted of Cdc7. J Biol Chem. 283:25171–25177. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kim JM, Kakusho N, Yamada M, Kanoh Y, Takemoto N and Masai H: Cdc7 kinase mediates Claspin phosphorylation in DNA replication checkpoint. Oncogene. 27:3475–3482. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Tan Y, Raychaudhuri P and Costa RH: Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes. Mol Cell Biol. 27:1007–1016. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Daily D, Vlamis-Gardikas A, Offen D, Mittelman L, Melamed E, Holmgren A and Barzilai A: Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways. J Biol Chem. 276:21618–21626. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Enoksson M, Fernandes AP, Prast S, Lillig CH, Holmgren A and Orrenius S: Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem Biophys Res Commun. 327:774–779. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Diotte NM, Xiong Y, Gao J, Chua BH and Ho YS: Attenuation of doxorubicin-induced cardiac injury by mitochondrial glutaredoxin 2. Biochim Biophys Acta. 1793:427–438. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Lillig CH, Lonn ME, Enoksson M, Fernandes AP and Holmgren A: Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide. Proc Natl Acad Sci USA. 101:13227–13232. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Wu H, Xing K and Lou MF: Glutaredoxin 2 prevents H(2)O(2)-induced cell apoptosis by protecting complex I activity in the mitochondria. Biochim Biophys Acta. 1797:1705–1715. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Conde-Pérezprina JC, León-Galván MÁ and Konigsberg M: DNA mismatch repair system: repercussions in cellular homeostasis and relationship with aging. Oxid Med Cell Longev. 2012:7284302012.PubMed/NCBI | |
|
Sirivolu VR, Vernekar SK, Marchand C, Naumova A, Chergui A, Renaud A, Stephen AG, Chen F, Sham YY, Pommier Y and Wang Z: 5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I. J Med Chem. 55:8671–8684. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Alagoz M, Gilbert DC, El-Khamisy S and Chalmers AJ: DNA repair and resistance to topoisomerase I inhibitors: mechanisms, biomarkers and therapeutic targets. Curr Med Chem. 19:3874–3885. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Rizo A, Olthof S, Han L, Vellenga E, de Haan G and Schuringa JJ: Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis. Blood. 114:1498–1505. 2009.PubMed/NCBI | |
|
Bhattacharyya J, Mihara K, Yasunaga S, Tanaka H, Hoshi M, Takihara Y and Kimura A: BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia. Ann Hematol. 88:333–340. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Datta S, Hoenerhoff MJ, Bommi P, Sainger R, Guo WJ, Dimri M, Band H, Band V, Green JE and Dimri GP: Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. Cancer Res. 67:10286–10295. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hoenerhoff MJ, Chu I, Barkan D, Liu ZY, Datta S, Dimri GP and Green JE: BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases. Oncogene. 28:3022–3032. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Merkerova M, Bruchova H, Kracmarova A, Klamova H and Brdicka R: Bmi-1 over-expression plays a secondary role in chronic myeloid leukemia transformation. Leuk Lymphoma. 48:793–801. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Danisz K and Blasiak J: Role of anti-apoptotic pathways activated by BCR/ABL in the resistance of chronic myeloid leukemia cells to tyrosine kinase inhibitors. Acta Biochim Pol. 60:503–514. 2013.PubMed/NCBI | |
|
Yang J, Chai L, Liu F, Fink LM, Lin P, Silberstein LE, Amin HM, Ward DC and Ma Y: Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells. Proc Natl Acad Sci USA. 104:10494–10499. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA and Lawler S: Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 68:9125–9130. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Wu XM, Liu X, Bu YQ, Sengupta J, Cui HJ, Yi FP, Liu T, Yuan CF, Shi YY and Song FZ: RNAi-mediated silencing of the Bmi-1 gene causes growth inhibition and enhances doxorubicin-induced apoptosis in MCF-7 cells. Genet Mol Biol. 32:697–703. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Venkataraman S, Alimova I, Fan R, Harris P, Foreman N and Vibhakar R: MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. PLoS One. 5:e107482010. View Article : Google Scholar : PubMed/NCBI | |
|
Nowak K, Kerl K, Fehr D, Kramps C, Gessner C, Killmer K, Samans B, Berwanger B, Christiansen H and Lutz W: BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas. Nucleic Acids Res. 34:1745–1754. 2006. View Article : Google Scholar : PubMed/NCBI |
